scholarly journals Correction to: Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell Lymphoma

2021 ◽  
Author(s):  
Ken Ogasawara ◽  
Michael Dodds ◽  
Timothy Mack ◽  
James Lymp ◽  
Justine Dell’Aringa ◽  
...  
Keyword(s):  
T Cell ◽  
B Cell ◽  
Chimeric Antigen Receptor ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Cell Product ◽  
Cellular Kinetics ◽  
Large B Cell Lymphoma ◽  
Kinetics Of ◽  
Large B Cell

scholarly journals Rapid tumor regression from PD-1 inhibition after anti-CD19 chimeric antigen receptor T-cell therapy in refractory diffuse large B-cell lymphoma

2019 ◽  
Vol 55 (6) ◽  
pp. 1184-1187 ◽  
Author(s):  
Brian T. Hill ◽  
Zachary J. Roberts ◽  
Allen Xue ◽  
John M. Rossi ◽  
Mitchell R. Smith
Keyword(s):  
T Cell ◽  
Cell Therapy ◽  
B Cell ◽  
Chimeric Antigen Receptor ◽  
Cell Lymphoma ◽  
Tumor Regression ◽  
B Cell Lymphoma ◽  
T Cell Therapy ◽  
Large B Cell Lymphoma ◽  
Large B Cell

scholarly journals Understanding and Managing Large B Cell Lymphoma Relapses after Chimeric Antigen Receptor T Cell Therapy

2019 ◽  
Vol 25 (11) ◽  
pp. e344-e351 ◽  
Author(s):  
Michael Byrne ◽  
Olalekan O. Oluwole ◽  
Bipin Savani ◽  
Navneet S. Majhail ◽  
Brian T. Hill ◽  
...  
Keyword(s):  
T Cell ◽  
Cell Therapy ◽  
B Cell ◽  
Chimeric Antigen Receptor ◽  
Cell Lymphoma ◽  
Antigen Receptor ◽  
B Cell Lymphoma ◽  
T Cell Therapy ◽  
Large B Cell Lymphoma ◽  
Large B Cell

scholarly journals Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma

Blood ◽  
2021 ◽  
Author(s):  
Jonathan A. Trujillo ◽  
James Godfrey ◽  
Yifei Hu ◽  
Jun Huang ◽  
Sonali M Smith ◽  
...  
Keyword(s):  
T Cell ◽  
Cell Therapy ◽  
B Cell ◽  
Chimeric Antigen Receptor ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Primary Resistance ◽  
T Cell Therapy ◽  
Large B Cell Lymphoma ◽  
Large B Cell

scholarly journals Liquid biopsy for disease monitoring after anti‐CD19 chimeric antigen receptor T cell in diffuse large B‐cell lymphoma

eJHaem ◽  
2020 ◽  
Author(s):  
Clara Maluquer ◽  
Beatriz Bellosillo ◽  
Alberto Mussetti ◽  
Eva Domingo‐Domènech ◽  
Rocío Parody ◽  
...  
Keyword(s):  
T Cell ◽  
B Cell ◽  
Chimeric Antigen Receptor ◽  
Liquid Biopsy ◽  
Cell Lymphoma ◽  
Antigen Receptor ◽  
B Cell Lymphoma ◽  
Disease Monitoring ◽  
Large B Cell Lymphoma ◽  
Large B Cell
Sign in / Sign up

Export Citation Format

Share Document